Research
Metabolic adaptation
GLP-1 receptor agonist patients experienced greater weight loss (7.8 kg) compared to controls (0.5 kg), with statistical significance (p<0.001).
Weight management strategies may be more effective in patients using GLP-1 receptor agonists.
StrongSupportsmedium confidence
Despite achieving greater weight loss (7.8 kg vs. 0.5 kg, p<0.001).
Why this rating
Based on a retrospective comparative case series design.
Source
Breast implant explantation with mastopexy in patients using GLP-1 receptor agonizts: A retrospective comparative analysis
Or Friedman et al. · Journal of Plastic Reconstructive & Aesthetic Surgery · 2025
DOI 10.1016/j.bjps.2025.09.028
other · n=60Cited 5×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- GLP-1 receptor agonist patients demonstrated higher overall complication rates (20%) compared to controls (10%), though this was not statistically significant (p=0.47).Strong
- GLP-1 receptor agonist patients had significantly lower serum albumin (4.06 g/dL) and prealbumin levels (23.52 mg/dL) compared to controls (4.22 g/dL and 25.55 mg/dL, respectively).Strong
Related findings · Metabolic adaptation
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →